CA-NEXON-AMERICA
Prepare for a thrilling ride as free-to-play mobile kart racer, KartRider Rush+ , launches on iOS and Android devices on May 12. Buckle up to experience a robust set of tracks, innovative and diverse game modes and countless kart customization options that redefine the world of kart racing games.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200511005971/en/
The latest iteration of the insanely popular KartRider franchise, KartRider Rush+ features over 50 race tracks and 20 karts at launch delivering unmatched kart and character customization options, ranging from decals, plates, skins and more.
KartRider Rush + is built for bursts of gameplay on the go or longer durations played with fellow racers offering something for everyone with several modes including:
- Story Mode: Story Mode allows players to fully immerse themselves in the game, learning about character backstories and showcasing various game modes.
- Speed Race Mode: This mode challenges racers to compete against each other and use their drifting skills to earn EXP that can unlock more challenging tracks.
- Arcade Mode: Whether playing solo or in teams, players can enjoy additional gameplay options within Arcade Mode, such as Item Race, Infini-Boost and Lucci Runner.
- Ranked Mode: From Bronze to Living Legend, players can rank up tiers and earn rewards such as K-Coins to purchase a variety of items in the Shop.
- Time Trial: This mode is all about beating the clock to become the fastest racer.
For players looking to achieve ultimate racing prowess, KartRider Rush+ introduces a Mentorship System, which allows racers to team up with mentors to improve their skills or sign up as mentors to guide other players. All players participating in this system will receive mentorship perks and rewards. The Club System also makes it easy for racers to join forces and work together to complete challenges, daily activities and earn rewards.
Additionally, all players will be able to claim the pre-registration milestone rewards until May 25th, 2020. Pre-registration rewards include Skelemech Kart, Slugger Dao Character, Angel Wing Headset, Star Driftmoji and Love Candy Balloon added as a bonus item after reaching 5 million pre-registrations ahead of launch.
To celebrate the launch, KartRider Rush+ has partnered with iconic peripheral manufacturer, HyperX. As part of the partnership, KartRider Rush+ will host giveaways of HyperX gaming peripherals including the HyperX Cloud MIX™ headset and the HyperX ChargePlay Clutch™ designed for longer, more comfortable gaming sessions.
KartRider Rush+ will be available globally in multiple languages including English, Korean, Thai, and Traditional Chinese. Visit https://kartrush.nexon.com for the latest updates and information.
Social Media: Twitch / Facebook / Twitter / Instagram / YouTube
Press Assets:
About KartRider Rush+ https://kartrush.nexon.com
Based on the popular online gaming phenomenon, KartRider , KartRider Rush+ is a free-to-play kart racing mobile game delivering all the racing action of its namesake on iOS and Android devices. With gorgeous 3D graphics, KartRider Rush+ offers players robust tracks, karts and game modes, just like its online counterpart accommodating every level, from racing novice to drifting champion.
About Nexon America Inc. http://www.nexon.net/corporate/about-nexon/
Founded in 2005, Nexon America Inc. delivers outstanding free-to-play online game expertise and live game support, taking the strengths of NEXON Co., Ltd. (“Nexon”) and applying them for uniquely western audiences. Nexon America has consistently sustained iconic franchises such as MapleStory and Mabinogi for more than a decade, which have gone on to break records and captivate players. With new projects on the horizon, Nexon America maintains the pioneering and innovative spirit of its parent company, employing its player-first approach, while designing the best possible gameplay experiences for the western market.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200511005971/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom